# Atopix Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atopix-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Abingdon, UK
- Website: www.atopixtherapeutics.com
- Total disclosed funding: $10M
- Latest round: Series A (Jul 21, 2014)
- Investors on record: 6

## About

Established in 2012 and based in UK, Atopix Therapeutics Ltd is a biopharmaceutical company that develops oral anti-allergic medicines to treat asthma, chronic allergic conditions and other atopic diseases.

## Funding rounds

- Series A, Jul 21, 2014, $4.4M — SR One
- Series A, Oct 17, 2013, $5.9M — Wellington Partners, SV Health Investors, Red Abbey, Bessemer Venture Partners, MPM BioImpact

## Investors

- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series A
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A
- Red Abbey (https://capitalatlas.ai/funds/red-abbey) — Series A
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series A
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A